Medicure (OTCMKTS:MCUJF) Stock Price Crosses Above 50 Day Moving Average – Should You Sell?

Medicure Inc. (OTCMKTS:MCUJF)’s share price crossed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $1.54 and traded as high as $2.14. Medicure shares last traded at $2.0977, with a volume of 2,900 shares traded.

Medicure Stock Performance

The business’s 50-day moving average price is $1.54 and its 200-day moving average price is $1.05. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.64 and a current ratio of 0.97. The stock has a market cap of $21.90 million, a P/E ratio of -4.11 and a beta of 1.13.

Medicure (OTCMKTS:MCUJF) last posted its quarterly earnings data on Friday, August 14th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.05). Medicure had a negative return on equity of 54.55% and a negative net margin of 23.14%. The company had revenue of $5.36 million during the quarter, compared to analysts’ expectations of $2.45 million.

About Medicure

Medicure Inc is a Canadian specialty pharmaceutical company focused on the development and commercialization of cardiovascular medicines. The company is headquartered in Winnipeg, Manitoba, and has concentrated its commercial activities on products intended for use in hospital and acute-care settings.

Medicure’s principal product is AGGRASTAT (tirofiban hydrochloride), an intravenous antiplatelet medication used in the management of certain patients with acute coronary syndrome and other cardiovascular conditions.